Are you looking to disseminate your COVID-19 relevant IP?

COVID-19 e-licensing logo

Universities globally can now rapidly execute non-exclusive, free-of-charge licences for their IP using the dedicated non-commercial site COVID-19 e-licensing.

The site is being made available by UCLB to the TTOs of universities and selected research and governmental institutions across the world.

The project is part of UCLB’s contribution to the humanitarian efforts to pro-actively and rapidly disseminate COVID-19 technologies globally.

covid19.e-lucid.com

UCLB offers free hosting and licensing of IP meeting the following criteria:

• Fully developed, ready to be licensed.
• Licences can be time-limited but must be free of charge.
• Submitted by institution’s TTO only.

COVID19 e-licensing hompage

The COVID-19 e-licensing site is aligned to initiatives such as AUTM’s COVID-19 Licensing Guidelines and the COVID-19 Technology Access Framework.

COVID-19 e-licensing features:

• Licensee-friendly click-to-accept Terms.
• From licence request to download of digital materials in minutes, not days.
• Comprehensive reporting on your IP licensing (self-service).
• Licensors retain control:
– Define your Terms.
– Set your ‘licence check-out’ questions.
– Automated workflow enables simple approval/rejection of licensee orders.

We are already making an impact

The UCL and Mercedes-AMG F1 team that developed a breathing aid for use by the UK’s NHS, were able to make the design files rapidly available to a global audience using UCL’s e-lucid platform. In the first 48 hours from release of the files, 1100 licence requests were reviewed and 700 licences approved.

If you would like to find out more, please contact covid-19@uclb.com

The COVID-19 e-licensing site is powered by

e-lucid logo